192 related articles for article (PubMed ID: 30878973)
1. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
Meznaric M; Fumic K; Leonardis L
J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
[TBL] [Abstract][Full Text] [Related]
2. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
[TBL] [Abstract][Full Text] [Related]
3. Is early detection of late-onset Pompe disease a pneumologist's affair? A lesson from an Italian screening study.
Confalonieri M; Vitacca M; Scala R; Polverino M; Sabato E; Crescimanno G; Ceriana P; Antonaglia C; Siciliano G; Ring N; Zacchigna S; Salton F; Vianello A;
Orphanet J Rare Dis; 2019 Mar; 14(1):62. PubMed ID: 30832705
[TBL] [Abstract][Full Text] [Related]
4. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
Golsari A; Nasimzadah A; Thomalla G; Keller S; Gerloff C; Magnus T
Neuromuscul Disord; 2018 Mar; 28(3):257-261. PubMed ID: 29326002
[TBL] [Abstract][Full Text] [Related]
7. [Alarming signs and symptoms in the early diagnostics of late onset Pompe disease: super omnia clinica].
Nikitin SS; Kurbatov SA; Bredelev VA; Kovalchuk MO
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):19-24. PubMed ID: 26978490
[TBL] [Abstract][Full Text] [Related]
8. A database for screening and registering late onset Pompe disease in Turkey.
Gokyigit MC; Ekmekci H; Durmus H; Karlı N; Koseoglu E; Aysal F; Kotan D; Ali A; Koytak PK; Karasoy H; Yaman A; Sengun İS; Sayin R; Tiftikcioglu BI; Soysal A; Tutkavul K; Bayrak AO; Kısabay A; Elci MA; Yayla V; Yılmaz İA; Ozdamar SE; Erdogan C; Tasdemir N; Serdaroglu Oflazer P;
Neuromuscul Disord; 2018 Mar; 28(3):262-267. PubMed ID: 29395671
[TBL] [Abstract][Full Text] [Related]
9. Screening for late-onset Pompe disease in western Denmark.
Hansen JS; Pedersen EG; Gaist D; Bach FW; Vilholm OJ; Sandal B; Weitemeyer L; Nielsen K; Schlesinger FE; Preisler N; Vissing J; Andersen H
Acta Neurol Scand; 2018 Jan; 137(1):85-90. PubMed ID: 28832912
[TBL] [Abstract][Full Text] [Related]
10. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
Hobson-Webb LD; Proia AD; Thurberg BL; Banugaria S; Prater SN; Kishnani PS
Mol Genet Metab; 2012 Aug; 106(4):462-9. PubMed ID: 22664150
[TBL] [Abstract][Full Text] [Related]
11. White matter lesions in treated late onset Pompe disease are not different to matched controls.
Schneider I; Hensel O; Zierz S
Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
[TBL] [Abstract][Full Text] [Related]
12. Screening for late-onset Pompe disease in Internal Medicine departments in Spain.
López-Rodríguez M; Torralba-Cabeza MA; de Pedro IP; Rivera A; Gil RS; Gómez-Belda A; de la Peña JLP; de Los Santos Moreno A; Selva-O'Callaghan A; Gárate IG; García AG; Hurtado R; de Ureta PT; Barba-Romero MÁ; Milisenda JC; Grau-Junyent JM;
Orphanet J Rare Dis; 2023 Aug; 18(1):256. PubMed ID: 37653444
[TBL] [Abstract][Full Text] [Related]
13. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
14. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
[TBL] [Abstract][Full Text] [Related]
15. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
[TBL] [Abstract][Full Text] [Related]
16. The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.
Feeney EJ; Austin S; Chien YH; Mandel H; Schoser B; Prater S; Hwu WL; Ralston E; Kishnani PS; Raben N
Acta Neuropathol Commun; 2014 Jan; 2():2. PubMed ID: 24383498
[TBL] [Abstract][Full Text] [Related]
17. Pompe disease: An Indian series diagnosed on muscle biopsy by ultrastructural characterization.
Kakkar A; Sharma MC; Nambirajan A; Gulati S; Bhatia R; Suri V; Sarkar C
Ultrastruct Pathol; 2018; 42(3):211-219. PubMed ID: 29565761
[TBL] [Abstract][Full Text] [Related]
18. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
[TBL] [Abstract][Full Text] [Related]
19. Toward deconstructing the phenotype of late-onset Pompe disease.
Schüller A; Wenninger S; Strigl-Pill N; Schoser B
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
Savarese M; Torella A; Musumeci O; Angelini C; Astrea G; Bello L; Bruno C; Comi GP; Di Fruscio G; Piluso G; Di Iorio G; Ergoli M; Esposito G; Fanin M; Farina O; Fiorillo C; Garofalo A; Giugliano T; Magri F; Minetti C; Moggio M; Passamano L; Pegoraro E; Picillo E; Sampaolo S; Santorelli FM; Semplicini C; Udd B; Toscano A; Politano L; Nigro V
Neuromuscul Disord; 2018 Jul; 28(7):586-591. PubMed ID: 29880332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
